Patent details

Basic Information

Publication number:

EP3207938

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171636384

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CTLA-4 VARIANTS

French Title of Invention:

VARIANTS DE CTLA-4

German Title of Invention:

CTLA-4 VARIANTEN

SPC Number:

Dates

Filing date:

11/03/2013

Grant date:

25/12/2019

EP Publication Date:

23/08/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/12/2019

EP B1 Publication Date:

25/12/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/03/2020

Expiration date:

11/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/12/2019

 

 

Name:

MedImmune Limited

Address:

Milstein Building Granta Park, Cambridge CB21 6GH, United Kingdom (GB)

Inventor

1

Name:

MINTER, Ralph

Address:

United Kingdom (GB)

2

Name:

RUST, Steven

Address:

United Kingdom (GB)

3

Name:

PRIVESENTZEV, Cyril

Address:

United Kingdom (GB)

4

Name:

BOWEN, Michael

Address:

United States (US)

5

Name:

MOISAN, Jacques

Address:

United States (US)

6

Name:

DOUTHWAITE, Julie

Address:

United Kingdom (GB)

Priority

Priority Number:

201261645686 P

Priority Date:

11/05/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; C07K 14/705;

Publication

European Patent Bulletin

Issue number:

201952

Publication date:

25/12/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages